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Abstract A novel and disposable cartridge for chemilumi-nescent (CL)-lateral flow immunoassay (LFIA) with integrat-ed 
amorphous silicon (a-Si:H) photosensors array was devel-oped and applied to quantitatively detect human serum albu-min (HSA) 
in urine samples. The presented analytical method is based on an indirect competitive immunoassay using horse-radish peroxidase 
(HRP) as a tracer, which is detected by adding the luminol/enhancer/hydrogen peroxide CL cocktail. The system comprises an 
array of a-Si:H photosensors depos-ited on a glass substrate, on which a PDMS cartridge that houses the LFIA strip and the reagents 
necessary for the CL immunoassay was optically coupled to obtain an integrated analytical device controlled by a portable read-
out electronics. The method is simple and fast with a detection limit of 2.5 mg L
−1
 for HSA in urine and a dynamic range up to 
850 mg L
−1
, which is suitable for measuring physiological levels of HSA in urine samples and their variation in different 
diseases (micro- and macroalbuminuria). The use of CL de-tection allowed accurate and objective analyte quantification in 
a dynamic range that extends from femtomoles to pico-moles. The analytical performances of this integrated device were 
found to be comparable with those obtained using a charge-coupled device (CCD) as a reference off-chip detector. These 
results demonstrate that integrating the a-Si:H photosensors array with CL-LFIA technique provides com-pact, sensitive and 
low-cost systems for CL-based bioassays with a wide range of applications for in-field and point-of-care bioanalyses. 
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 Introduction 
 
In the last years, lateral flow immunoassays (LFIAs) have gained wide popularity and commercial success among the methods used for 
point-of-care (POC) applications. This ana-lytical technique owes such achievements to the simplicity and rapidity of assay execution, as 
well as compactness, low cost and ease of use of LFIA devices. Indeed, LFIAs combine the advantages of immunoassays, such as 
applicability to a wide range of analytes, high specificity, high detectability and little or no need for preanalytical sample preparation, with 
the simplic-ity and rapidity of the immunochromatographic format [1].  
defined positions along the strip determines the formation of coloured bands that are visually detected to provide a qualita-tive 
result (i.e., presence or absence of the analyte in the sam-ple) or measured with a suitable device (an optical scanner or a 
smartphone-embedded camera) to provide objective, semi-quantitative information [2–4]. The use of alternative labels has 
recently gained wide acceptance, showing advantages in terms of assay sensitivity, but at the expense of assay simplic-ity and 
non-instrumental requirements. Many works reported the combination of LFIA technique with enzyme labels [5, 6], fluorescent 
nanoparticles [7–9], electrochemical probes [10] and magnetic nanoparticles [11], providing high assay sensi-tivity and 
reproducibility and wide linear ranges.  
Chemiluminescence (CL) detection of enzyme-labelled biospecific reagents has been proposed as an ideal method for miniaturization 
and POC biosensor development thanks to its inherent sensitivity, specificity and rapidity [12, 13]. In particular, ultrasensitive CL detection 
combined with LFIA technique (CL-LFIA) has been demonstrated to provide supe-rior analytical performance, yielding biosensors 
characterized by high detectability, amenability to miniaturization and short assay times. In addition, the instrumentation required for the 
readout of the CL signal from LFIA strips is much simpler and amenable to miniaturization with respect to that required for colloidal gold 
or fluorescence-based detection, since no exter-nal illumination is required. Inhomogeneous illumination of the LFIA strip is a greatly 
underestimated source of error in scanning- or imaging-based readers, which is instead avoided when CL detection is exploited. In addition, 
the intensity of illumination is also very important to achieve the best detect-ability, especially for fluorescence-based assays, and this re-
quires a large light power that hampers portability [14]. To this end, light imaging systems based on a charge-coupled-device (CCD) 
camera [15–17] or even a smartphone’s complemen-tary metal-oxide semiconductor (CMOS) sensor [18] was employed for photons 
detection in CL-LFIAs. 
 
Nevertheless, all of these approaches rely on Boff-chip^ coupling of the analytical support (the LFIA strip) and the 
detection device. While CCDs and CMOS are difficult to miniaturize into low-cost, portable detection devices, thin-film 
photodiodes have been successfully integrated in microfluidic systems in order to achieve ultrasensitive detec-tion of 
analytes and to reduce the cost of diagnostic platforms. In particular, hydrogenated amorphous silicon (a-Si:H) photo-diode 
arrays [19] and organic photodiodes (OPDs) [20] have been integrated into microfluidic devices and employed for measuring 
UV absorbance [21], fluorescence [22, 23] and CL signals [24–28].  
Here we report for the first time a disposable CL-LFIA cartridge with integrated a-Si:H photosensors as CL detectors, which 
are controlled through a portable custom electronics. The add-on assembly comprises two parts: a glass slide on which an array of 
thin film a-Si:H photosensors has been  
deposited and a polydimethylsiloxane (PDMS) microfluidic cartridge that houses the LFIA strip and necessary reagents. Once the 
operator has carried out the assay on the LFIA strip, the cartridge and the array of photosensors are assembled to perform the CL 
measurements in an integrated device.  
In this work, we applied the developed biosensor for the quantitative detection of human serum albumin (HSA) in urine samples, 
which is considered a biomarker suitable to identify and monitor patients with kidney damage [29]. Normal HSA level in urine is 
lower than 25 mg L
−1
. A higher level of HSA corresponds to the situation of microalbuminuria (in the concentration range between 
25 and 200 mg L
−1
) or macroalbuminuria (above 200 mg L
−1
) [30].  
Indeed, the level of urinary albumin excretion indicates kidney damage and it is recognized as a risk factor for pro-gression of 
kidney disease and damage [29]. In particular, the condition of microalbuminuria can be used to predict diabetic nephropathy [31]. 
Diabetes is a chronic illness that requires continuing medical care and patient self-management educa-tion to prevent acute 
complications and to reduce the risk of long-term complications. Generally, while type I diabetes is manifested by acute symptoms 
such as markedly elevated blood glucose levels, type II diabetes is frequently not diag-nosed until complications appear. Diabetic 
nephropathy oc-curs in 20–40 % of patients with diabetes and is the single leading cause of end-stage renal disease (ESRD). 
Persistent microalbuminuria has been shown to be the earliest stage of diabetic nephropathy in type I diabetes and a marker for de-
velopment of nephropathy in type II diabetes. Patients with microalbuminuria who progress to macroalbuminuria are like-ly to 
progress to ESRD over a period of years [32]. The pos-sibility to promptly detect kidney damage allows starting treatment when 
the damage is minimal and reversible and the monitoring of urinary albumin represents a principal com-ponent of treatment for 
both type I and type II diabetes mellitus [33]. Moreover, higher rates of cardiovascular disease (CVD) are seen in patients with 
moderate and even mild renal dysfunction. Recent studies have indicated that even modest elevations in serum creatinine and 
urinary albumin excretion are associated with increased CVD risk, not only in subjects with diabetes or hypertension but also in 
the general popula-tion [34]. Therefore monitoring HSA can be useful for both diabetic and healthy patients in order to prevent 
future renal and cardiovascular adverse events [35].  
The developed assay must therefore provide reproducible quantitative information in a very wide dynamic range in or-der to 
detect disease-related variations.  
We optimized an indirect competitive immunoassay, in which HSA in urine and HSA immobilized on the nitrocellu-lose 
membrane compete for anti-HSA antibody. The detection is performed using horseradish peroxidase (HRP)-labelled 
secondary antibodies and adding the CL luminol/enhancer/ hydrogen peroxide cocktail. 
  
  
 
The proposed biosensor allows objective and accurate quantification of HSA in urine samples in the relevant physi-ological 
range, thus enabling rapid and reliable identification of those samples requiring confirmatory analysis. 
 
 
Materials and methods 
 
Chemicals 
 
Polyclonal anti-human albumin antibody produced in rabbit, polyclonal anti-peroxidase (HRP) antibody produced in rab-bit, HRP-
labelled goat anti-rabbit immunoglobulin, human serum albumin and bovine serum albumin were purchased from Sigma-Aldrich 
(St. Louis, MO).  
All other reagents were of analytical grade and were used as purchased.  
The SuperSignal ELISA Femto CL substrate for HRP was obtained from Thermo Fisher Scientific, Inc. (Rockford, IL).   
Nitrocellulose membranes (Hi-flow180 A4 sheet) and cellulose adsorbent pads (20 × 300 mm) were bought from 
Merckmillipore (Billerica, MA). Sample pads were Standard 14 glass fibre pads (22 × 300 mm) from Whatman and were 
purchased from GE Healthcare Life Sciences (Buckinghamshire, UK).  
Phosphate-buffered saline (PBS) was prepared as follows: 10 mmol L−
1
 Na2HPO4, 2 mmol L
−1 KH2PO4, 137 mmol L
−1  
NaCl, 2.7 mmol L
−1
 KCl (pH 7.4). 
Synthetic urine was prepared as previously described [36]. 
 
LFIA strips preparation 
 
Assay strips for LFIA were prepared by using A4 sheets of nitrocellulose membranes with transparent backing. The mem-branes were 
previously cut into 2.5 cm high sections (250 × 297 mm) and the human serum albumin (T-line) and the rabbit anti-peroxidase antibody 
(C-line) were immobilized, from bottom to top of the strip, keeping a distance of 5.5 mm. After line dispensing, two adhesives were pasted 
onto the top and the bottom of the membrane to assemble the sample and adsorbent pads, respectively. Overlapping of the adhesive and 
pads with the membrane was maintained as narrow as possible that resulted in a transparent window of 140 mm high. Finally, the 
membranes were cut into strips of 5.4 mm width. 
 
Photosensor array and electronic read-out board 
 
As previously described [28], the photosensors array is a 5 × 6 matrix of a-Si:H diodes. Each photosensors is a p-type/intrin-sic/n-
type structure grown on glass substrate by a three-chamber high-vacuum plasma enhanced chemical vapor de-position (PECVD). 
In particular, the fabrication process has been implemented with the following technological
 steps: (a) cleaning of a 5 × 5 cm
2
 glass substrate by piranha solution; (b) deposition by magnetron sputtering and patterning 
by photolithographic processes of a 200-nm-thick layer of Indium tin oxide (ITO) acting as front electrode of the a-Si:H 
photosensor; (c) deposition of the a-Si: layers; (d) deposition by vacuum evaporation of a 30/150/30-nm-thick stack of 
Al/Cr/Al as back con-tact; (e) patterning of the metal stack and of the a-Si:H layers to define the photosensor geometries; 
(d) deposi-tion and patterning of a 5-μm-thick layer of SU-8 3005 acting as insulation layer; (e) deposition by vacuum 
evaporation and patterning by photolithographic process-es of a 30/150/30-nm-thick stack of Al/Cr/Al to define the electrical 
connections to the metal pad of the back contact. In this device configuration, light is impinging on the a-Si:H photosensor 
through the glass and the ITO layer. 
 
A qualitative illustration of the cross section of one photosensor is reported in Fig. 1, also showing a picture of the 
photosensors array.  
The light-grey squares in the middle of the picture are the 30 a-Si:H photosensors. The C-shaped line is the metal back 
contact, which is common to all the photosensors, while the ITO transparent front contacts (one for each di-ode) end with 
the short metal contacts visible on the lower edge of the glass substrate.  
These metal contacts allow an easier alignment of the photosensor array with the card edge connector (SAMTEC MB1–150–01–L–
S–02–SL), which in turn is connected through a simple interface board to the read-out electronics. The input stage of read-out circuit is 
based on an eight-channel, 20-bit analog-to-digital converter (DDC118 from Texas Instruments), which receives the currents generated 
by the 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1 Cross section of the photosensor structure, reporting the thickness of the different layers. The metal back contact is a double stack of Cr/Al/Cr layers with 
thicknesses equal to 30/150/30 nm, respectively. Inset: picture of the photosensor array fabricated on a 5 × 5-cm
2
 glass substrate 
 
 
photodiodes, provides the current-to-voltage conversion through a charge sensing amplifier and digitizes them thanks to the internal sigma-
delta modulator. The results are presented at the output of a synchronous serial interface driven by a clock signal. The master of the read-
out circuit is a PIC18F4550 microcontroller (from Microchip) that has two main functions:  
(1) providing the timing and control signals to the DDC; (2) ensuring the communication to a PC. A software running on the 
computer sets all the measurement parameters through a USB port, stores and visualizes the measurement data. 
 
Analytical device 
 
The disposable analytical cartridge comprises a PDMS fluidic element that houses the LFIA nitrocellulose membrane and contains 
all the reagents necessary for the analysis (Fig. 2).  
In more detail, the fluidic element contains three reagent reservoirs: a 50-μL reservoir for the immunoreagents solution 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 a Picture of the PDMS microfluidic cartridge enclosing the CL-LFIA strip and reagents and equipped with the ABS 3D printed frame. b Exploded view of the 
components of the PDMS microfluidic cartridge components  
 and two 40-μL reservoirs for the two components of the SuperSignal ELISA Femto HRP CL cocktail. The immunoreagents 
solution was PBS containing 3 % (w/v) BSA, anti-HSA antibody (diluted 1:2000, v/v) and HRP-labelled anti-rabbit antibody 
(diluted 1:5000, v/v).  
In addition, hollow spaces were engraved in the PDMS fluidic element in the correspondence of the LFIA strip to facilitate 
water evaporation, thus further promoting the capil-lary flow along the strip. A 3D-printed ABS frame encloses the PDMS element 
in order to assure its reproducible position-ing in the correspondence of the photodiodes array. This is critical to assure the correct 
readout of the CL signals. Indeed, four aligned photodiodes was used to measure the CL signal from the strip: two of them, placed 
in the correspon-dence of the test and control lines of the strip, respectively, measured the analytical signals; the others were placed 
in blank areas of the LFIA strip (i.e. just before and after the lines) to perform background correction (Fig. 3).  
Since this approach has not previously been used to acquire CL signals from LFIA membranes, the analytical performance 
of the photodiodes was compared with that of a conventional ultrasensitive CCD camera (MZ-2PRO from MagZero, 
Pordenone, Italy, equipped with a Sony ICX285 sensor), coupled with a round fibre optic taper (25/11 mm size, Edmund 
Optics, Barrington, NJ) placed in contact with the CCD sensor. This set-up had been previously used to develop CL-LFIA 
methods in a contact imaging configuration [15, 17]. 
 
Assay procedure 
 
For the analysis, 10 μL of sample was transferred with a syringe into the prefilled immunoreagents reservoir, in order to mix 
the sample with the solution of rabbit anti-HSA anti-body and HRP-labelled anti-rabbit antibody. By squeezing the reservoir, 
the solution reached the sample pad and began flowing across the membrane where the immunoreactions took place. Upon 
complete migration of the solution (30 min), the CL substrate was added to the strip by simulta-neously pushing the two 
dedicated reservoirs. After inserting the cartridge on the photodiodes array (Fig. 3) and enclosing the system in a dark box, 
the CL signals were monitored through consecutive 200-ms acquisitions (total acquisition time 2 min).  
Calibration curves for HSA were produced employing stan-dard solutions prepared by adding HSA to synthetic urine to 
the desired concentration, comprised between 0 (blank) and 2500 mg L
−1
. 
To obtain quantitative information, the mean photon emis-sion intensity was measured in the areas corresponding to C-line and 
T-line of the LFIA strip. In addition, background signal was recorded in two areas of the nitrocellulose mem-brane: just before and 
after the lines (Fig. 3). 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 a Scheme of the CL-LFIA strip showing the assay principle (top) and the position of the photosensors below the strip (bottom). b Picture of the 
complete device, comprising the PDMS microfluidic cartridge with integrated a-Si:H photosensors and the custom readout electronics. c Typical output 
signal obtained for a single CL-LFIA strip 
 
 
 
 
The mean background was subtracted from the CL sig-nals recorded for the C-line and T-line, then the T-line/C-line ratio 
was calculated for each concentration and con-verted into B/B0 ratio by dividing it for the T-line/C-line ratio measured in 
the absence of the target analyte (B0, i.e. maximum T-line/C-line value). Finally, B/B0 ratio, which represents the fraction 
of the tracer that has been displaced by a specific concentration of the analyte, was plotted against the log of analyte 
concentration obtaining a sigmoi-dal curve that is described by a four-parameter logistic function. 
 
In particular, a non-linear regression analysis was per-formed using the following equation: 
 
ð Y 1−Y 0Þ  
Y
 
¼
 
Y
 
0
 
þ
 1 þ 10½ ðb−xÞc& 
 
where Y = B/B0, Y0 = bottom asymptote (the ∞ dose), Y1 = top asymptote (the 0 dose), x = log of analyte concentration 
(mg L
−1
), b = log of analyte at midpoint of curve (mg L
−1
), and c = slope.  
The intensity of the CL signal of the C-line above a defined threshold value was exploited to confirm the validity of the assay. 
The threshold value was defined by measuring the blank signal in 15 different strips and calculating the average blank signal plus 
10 times its standard deviation.  
To obtain the analyte concentration in real samples, B/B0 value was calculated as described above and interpolated on a 
stored calibration curve. 
 
 
Samples and spiked samples preparation 
 
Human urine samples were kindly provided by the Laboratory of Clinical Chemistry and Microbiology of the Umberto I 
Hospital (Turin, Italy). Clinical samples were available for research purposes according to Italian privacy law (decree 
196/2003, 1110).  
Confirmatory analyses were performed using the reference method Multigent Microalbumin assay on an Architect Ci8200® 
analyzer (Abbott, Abbot Park, IL, USA). 
 
 
 
Results and discussion 
 
Lateral flow immunoassays represent a well-established and very appropriate technology for developing easy-to-use and robust 
POC analytical devices. Their coupling with CL detec-tion has previously shown to improve analytical performance, including a 
higher sensitivity and the ability to provide quan-titative information [15–18]. This would therefore bring the range of applications 
as well as the analytical performance of LFIAs closer to that of conventional analytical instrumenta-tion. Nevertheless, CL-LFIAs 
require multiple steps and dif-ferent reagents; thus, LFIAs devices should be properly de-signed to maintain the peculiarities of the 
LFIA technique, such as its amenability for on-field application. In this con-text, it is also important to implement simple, easy-to-
use and cheap but still highly sensitive signal detectors to fully exploit the quantitative potentiality of CL detection [18]. Indeed, 
integration of LFIAs with objective measurement technologies is considered one of the key aspects for next generation LFIAs [1]. 
 
 In this work, we propose for the first time an array of thin-film a-Si:H photosensors as detector for CL-LFIA. The analytical 
performances of these sensors have been previ-ously demonstrated in bioanalytical applications such as enzyme assays, 
immunoassays and gene probe assays [19, 26, 27]. In order to develop a fully integrated device, we coupled the miniaturized 
detector with a disposable PDMS microfluidic cartridge that houses the LFIA strip and all the reagents required for performing the 
analysis and enables easy manual dispensing of the reagents accord-ing to the analytical protocol. This analytical device will thus 
combine the simplicity and specificity of LFIA assays with the sensitivity of CL as reporting technique and with the low cost and 
easy integration of thin-film a-Si:H photosensors in miniaturized, portable instrumentation. 
 
Photosensor array and electronic read-out board 
 
The photosensor array was designed to enable high detectabil-ity for the CL signals. In particular, basing on simulation re-sults 
performed with a numerical simulator previously devel-oped by the authors [37], the p-layer thickness has been set to 10 nm. 
Indeed, taking into account that the active region is the intrinsic layer, while the doped layers do not contribute to the photocurrent 
signal, thickness and energy gap of the p-doped layer have to be carefully designed. In particular, this region has to be thick enough 
to sustain the built-in potential, but, at the same time, as thin as possible to reduce the absorption of the radiation.  
In addition, in order to further reduce its absorption, the p-doped film has been grown by a mixture of silane, diborane and 
methane. Indeed, the methane presence ensures an in-crease of the energy gap (from 1.72 to about 2 eV) and there-fore a decrease 
of the carriers photogenerated in this layer.  
The area of each diode (2 × 2 mm
2
) and the pitch of the array (5 mm), which result in a minimum distance between the 
photosensors equal to 3 mm, were adopted to ensure a reduced crosstalk effect [38].  
The photosensor characterization has been carried out mea-suring the current–voltage characteristics (IV) in dark condi-tion 
and the spectral response in the visible range. The IV curves have been measured by a Source Measure Unit Keithley 236 in a 
metal shielded box to avoid the effect of electromagnetic interferences. The spectral response has been measured by a double-arm 
optical set-up, which includes a Jobin-Yvon SPEX monochromator, a halogen lamp as radia-tion source, a beam splitter, a 
calibrated crystalline photodiode from Hamamatsu and lenses for focusing the light. Two Keithley 236 Source Measure Units read-
out the photocur-rents of the reference diode and of the a-Si: photosensors. We found a very well reproducibility over the all 
photosensors of the array with standard deviations around 3 % for both the IV and responsivity curves. 
 
 From the IV characteristics, we found that the dark current at small reverse voltage (few mV) is around 2 pA. This value 
corresponds to a current noise equal to 1 fA.  
Results of the spectral response are reported in Fig. 4, where we infer that at 425 nm, the wavelength corresponding to 
the emission peak of the CL reaction, the responsivity R is equal to 170 mA/W.  
From the characterization of the whole system (read-out electronics connected to the photosensors), we found that in the 
operating conditions utilized during the CL measurements (200 ms integration time and 50 pF integration capacitance), the total 
current noise in is around 40 fA. Taking into account the definition of noise equivalent power (NEP), i.e. the inci-dent power that 
provides an output signal equal to the system noise in dark condition, we found that the minimum detectable power is 0.235 pW . 
 
qffiffiffiffi 
i
2
n  
NEP ¼ R 
 
Assuming that this power is due to photons at 425 nm, we deduce that the minimum detectable number of incident pho-
tons per second is 5 × 10
5
 for each photosensor. 
 
CL-LFIA assay principle 
 
In order to achieve high detectability and quantitative infor-mation, an indirect competitive CL-LFIA assay was devel-oped for 
HSA detection in urine (Fig. 3). The analyte in the sample (or in the standard solution) migrates along the LFIA nitrocellulose 
membrane together with rabbit anti-HSA anti-body and HRP-labelled anti-rabbit antibody. In correspon-dence of the T-line, the 
analyte competes with HSA immobilized on the nitrocellulose membrane for binding to the fixed and limited amount of anti-HSA 
in solution. At the 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Typical spectral response of the a-Si:H photosensors. A very good reproducibility (relative standard deviation around 3 %) has been achieved 
  
  
 
same time, the HRP-labelled anti-rabbit antibody binds to the anti-HSA antibody captured in the T-line area. Afterwards, 
unbound reagents continue to migrate until they reach the C-line, where the excess of HRP-labelled anti-rabbit antibody is 
captured by immobilized anti-HRP antibody. In the detection step, a CL cocktail for HRP was added to the strip and the 
resulting CL signal from both lines was recorded using the photodiodes array.  
Being a competitive type assay format, the intensity of the CL signal measured in the T-line is inversely related to the 
amount of HSA. The observation of a CL signal above a threshold value (blank signal plus 10 times its standard devi-ation) 
in the correspondence of the C-line confirms the correct assay execution.  
To obtain quantitative information, the T-line/C-line ratio was calculated for each HSA concentration, upon subtracting each 
signal of the mean background signal. The T-line/C-line ratio allows to normalize the CL signal of the T-line with respect to that 
of the C-line of the same strip, taking into account environmental and matrix factors that might affect the intensity of the CL signal 
(i.e. changes in ambient temper-ature, the presence of HRP inhibitors in the sample, etc.) thus improving the reproducibility of the 
assay.  
It is worth noting that, despite the fact that the target analyte is a protein, a competitive immunoassay was employed in-stead of a non-
competitive, sandwich-type immunoassay. Such format was preferred to reduce the overall cost of the assay, as a sandwich immunoassay 
would require two differ-ent specific anti-HSA antibodies, while in our assay only one specific antibody was required. In addition, the 
amount of capture antibody immobilized in the T-line of a LFIA strip for a typical sandwich immunoassay is 10–30 mg cm−
2
, which is 
25–100 times that used in microtitre plate sandwich immu-noassays [39]. In our assay, HSA was immobilized in the T-line area and the 
antibodies required for the assay were added in solution. This approach reduced the consumption of expen-sive immunospecific reagents, 
which is considered the main factor influencing the overall test cost-effectiveness. 
 
Cartridge design 
 
As previously stated, the addition of multiple reagents is re-quired to perform CL-LFIAs. Therefore, the PDMS microfluidic cartridge 
(Fig. 2) comprises reservoirs connected to the LFIA sample pad through fluidic channels that allow manual dispens-ing of the reagents 
onto the LFIA strip according to the analyt-ical protocol. In more detail, three reagent reservoirs, which contain the immunoreagents (anti-
HSA and HRP-labelled anti-rabbit antibodies) and the two components of the CL HRP de-tection cocktail, respectively, were engraved 
in the PDMS mod-ule. The PDMS cartridge, together with the ABS 3D printed frame, allows reproducible positioning of the LFIA strip 
on the a-Si:H photosensors array. 
 
Since the components of the CL HRP cocktail are in ex-cess, while a reproducible amount of sample and immunoreagents must be 
delivered to the strip, the reservoir containing the immunoreagents was placed in close proximity to the strip to reduce the dead volume 
of the fluidic channel. Indeed, it is known that reproducibility in LFIAs largely de-pends on the accurate delivery of sample to the strip 
and the subsequent movement of the sample and conjugates through the device to the reaction matrix [40]. The components of the CL 
cocktail (which accomplishes two different tasks, i.e. washing unbound immunoreagents from the strip and trigger-ing the HRP-catalysed 
CL reaction) are delivered to the strip by simultaneously pushing their reservoirs and mix upon dis-pensing onto the sample pad before 
flowing along the LFIA strip. To increase washing efficiency, the CL cocktail compo-nents are delivered to the strip at half-length of the 
sample pad. 
 
LFIA optimization 
 
Concentration of the immunoreagents were optimized to achieve limit of detection (LOD) and dynamic range suitable for detecting HSA 
in the relevant physiological range. In addi-tion, similar CL intensities must be obtained in the T-line and C-line to prevent excessive 
interference between the signals.  
The optimal concentration of HSA (1 mg/mL) and anti-HRP antibody (1:1000 v/v dilution) to be immobilized onto the 
nitrocellulose strip, as well of rabbit anti-HSA (1:2000 v/v dilution) and HRP-labelled anti-rabbit antibody (1:5000 v/v dilution), 
were selected (see Electronic Supplementary Material, ESM). These concentrations ensure the absence of crosstalk phenomena 
between C-line and T-line and produce a calibration curve that allows direct analysis of urine samples and discrimination between 
diagnostically relevant urinary HSA levels. 
 
Signal detection 
 
The production of a LFIA strip requires lamination of multiple materials into one unit. Lamination is usually performed by assembly of 
the LFIA components on a backing material that provides rigidity and easy handling of the strip. The backing materials are typically 
opaque white polystyrene or other plastic materials coated with an adhesive. On the contrary, a LFIA strip with transparent backing support 
was produced in this work to ensure high photon transmission, thus enabling direct measure-ment of the CL signal from the LFIA strip 
employing the array of a-Si:H photosensors aligned below the strip (Fig. 3). 
 
It is also worth noting that the nitrocellulose strip is also opaque, but it can be assumed that the immobilization of 
immunoreagents, and thus the consequent immunoreactions, takes place along the whole thickness of the strip. Therefore, 
CL signals can be measured indifferently from both sides without significant loss.  
 To further improve light collection efficiency and obtain a compact and miniaturized device, the LFIA strip enclosed in the 
transparent PDMS cartridge was placed in close contact with the photosensors array. In the proposed system, the dis-tance between 
the place where the CL reaction takes place and the detection site is extremely short (in the order of 1 mm, sum of the glass 
thickness and the bottom PDMS layer). This avoids the use lens for focusing the emitted radiation and allows a reduction of the 
system complexity and a high degree of miniaturization.  
The configuration used for the measurement of CL sig-nal thus leads to a hand-held device providing objective and 
accurate quantitative information. The device has no moving parts, differently from scanning systems, which increase its 
robustness.  
The array of photosensors controlled by the custom read-out electronics allowed to simultaneously measure the CL signal in all the 
relevant areas of the nitrocellulose membrane (Fig. 3), making it possible to obtain the values of CL signals related to T-line, C-line and 
their adjacent areas (for measuring the back-ground signal). For this purpose, all the photosensors must re-spond equally to light and the 
absence of crosstalk phenomena among adjacent photosensors must be assessed. The perfor-mances of the photosensors array in terms of 
background noise, detectability of chemiluminescent system and crosstalk phenom-ena had been previously evaluated [27]. Since this is 
the first report about coupling thin-film photosensors with CL-LFIA, light measurements were also performed by imaging with a por-
table, thermoelectrically cooled CCD camera that had already proved to be suitable detector for CL-LFIA approach in previ-ously works 
[15, 17]. The results showed that the array of photosensors allowed to measure CL intensity of each interest area without significant 
crosstalk and that its performance was similar to that obtained using the CCD camera. In Fig. S3 (ESM), CL signals obtained in 
correspondence of the T-line and C-line of various LFIA strips using a-Si:H photosensors are plotted against the same signals acquired 
with CCD camera in a Bcontact^ im-aging configuration. There is a clear correspondence between the signals measured by the two 
different platforms, showing that, as the CCD camera, even photosensors are suitable for the coupling with the CL-LFIA technique. This 
result is very encouraging considering that the a-Si:H photosensors were employed at room temperature (about 25 °C) while the CCD 
sensor was cooled down to 5 °C to decrease the background signal, which is mainly due to thermal noise. 
 
Another advantageous aspect is that the digital memory occupancy of the data measured using a-Si:H photosensors is 
significantly lower than those of data generated by image-based systems. This represents a benefit not only for the data 
storage, but also for the algorithm complexity and computing time for data analysis.  
Furthermore, the cost of production of the detector is much lower when manufactured at a large scale, as compared with 
 
 CCD-based detectors. Indeed, the a-Si:H technology is ma-ture, inexpensive and suitable for different kinds of substrate owing to 
its low deposition temperature. In particular, the thermal budget for the deposition of amorphous silicon (which occurs at 
temperature below 300 °C) is much lower than the thermal budget required by crystalline silicon, whose process temperature can 
reach 1000 °C.  
It is worth noting that in this work, 4 out of 30 a-Si:H photosensors of the array were employed. In the future, ded-icated arrays 
will be produced for CL-LFIA applications. 
 
Calibration curve 
 
Calibration curves were generated using HSA standard solu-tions in the range 0–2500 ng/mL, both in synthetic urine and in 
PBS to evaluate the matrix effect.  
The calibration curves are reported in Fig. 5. Being a com-petitive type format, a typical sigmoidal calibration curve was 
obtained by reporting the signal versus the logarithm of HSA concentration. Instead of the T-line signal alone, the T-line/C-line 
ratio was calculated and plotted against the analyte con-centration to improve assay reproducibility by taking into ac-count 
environmental and matrix factors that might affect the intensity of the CL signal (e.g. changes in ambient tempera-ture, presence 
of HRP inhibitors in the sample). In addition, to confirm the validity of the assay, a C-line minimum signal threshold above 
background was defined.  
The results of three repeated calibration curves demon-strated a good reproducibility with a coefficient of variation associated 
with each point of the calibration curve below 20 % both in buffer and in urine matrix. The limit of detec-tion (LOD) was estimated 
as the concentration correspond-ing to the blank T-line/C-line value minus three times its standard deviation. The obtained values 
were 2.5 mg L
−1
 in synthetic urine and 3.1 mg L
−1
 in PBS while the dynamic ranges of the method were 2.5–850 mg L−1 for 
synthetic urine and 3.1–842 mg L−1 in PBS, therefore showing a negligible matrix effect (Fig. 5). Moreover, no significant 
differences were observed by comparing calibration curves obtained using the a-Si:H photodiode array and the CCD sensor as CL 
detectors (Fig. 5).  
Figure 5 also shows dashed lines in correspondence of the HSA urinary levels that enable discrimination between normal 
subjects and those affected by micro- or macroalbuminuria. The assay was optimized in order to obtain a dynamic range of the 
calibration curve suitable for direct analysis of urine samples and quantitative analyte measurements in all the levels relevant for 
diagnostic purposes. It is worth noting that lower limits of detection of the assay could be obtained employing different 
experimental conditions, but these were not selected in this work to avoid the need for diluting the urine sample prior to the analysis, 
thus increasing the POC applicability of the test. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 a CL-LFIA calibration curves for HSA obtained by measuring the CL signals with the integrated a-si:H photosensors (black) or with a cooled CCD-based 
device employed in a Bcontact  ^imaging configuration (red). b CL-LFIA calibration curves for HSA obtained by preparing the HSA standard solutions in PBS (blue) 
or in synthetic urine (orange). c Typical signal outputs for a series of CL-LFIA strips employed to construct a calibration curve for HSA. T-line signals are shown in 
black, with the corresponding HSA concentration, while C-line signals are shown in grey 
 
Samples 
 
To confirm the accuracy of the proposed method, urine sam-ples provided by the Umberto I Hospital (Turin, Italy) were analysed 
using HSA calibration curves generated in synthetic urine. The results (mean of three independent measurements) were compared 
with those obtained using a reference turbidi-metric immunoassay, routinely employed in the Laboratory of Clinical Chemistry 
and Microbiology of the Umberto I Hospital (Turin, Italy). A good agreement between CL-LFIA and reference method results was 
found for all samples (Fig. 6). In detail, recovery values ranging from 85 to 112 % and coefficients of variation below 20 % were 
obtained, prov-ing the reliability and applicability of the proposed CL-LFIA for quantitative determination of HSA in urine 
samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6 Results obtained by analysing urine samples with the integrated device for CL-LFIA, as compared with those obtained with a reference 
immunoturbidimetric assay. Samples with HSA in the normal range are shown in green, while samples with HSA indicating microalbuminuria and 
macroalbuminuria are shown in orange and red, respectively 
 
These results provide a demonstration of the suitability of the proposed biosensor for the direct analysis of urine samples 
in POC settings. Its compactness and integration make it a user-friendly analytical device suitable for the quantitative 
evaluation of the level of urinary albumin excretion, thus for early diagnosis of diabetic nephropathy and prognosis of pro-
gression to ESRD. This will facilitate screening procedures, thus enabling early stage treatment and preventing irreversible 
kidney damage. 
 
 
 
Conclusions 
 
A novel integrated device was developed by coupling a PDMS cartridge, containing the LFIA strip and all the re-agents 
necessary to complete the analysis, with an array of thin film a-Si:H photosensors. The device was exploited to perform 
quantitative analysis of HSA in urine samples employing a CL-LFIA assay, showing its suitability for POC diagnostic 
applications.  
The developed biosensor overcomes the main shortcom-ings of conventional LFIAs, such as inconvenience in manual 
documentation and subjective interpretation, only allowing qualitative measurements and often leading to false negative and 
false positive results.  
Thanks to the solutions adopted in the device development, the features requested for POC applicability were fulfilled. In 
particular, reagent embedding and Si:H photosensors integra-tion provided speed of analysis, simplicity of operation and device 
portability. In addition, use of CL detection and opti-mization of assay experimental parameters enabled direct sample quantitative 
analysis, avoiding time-consuming sam-ple preparation steps.  
Taking advantage of the convergence between CL-LFIA and thin film photosensor deposition technologies, the report-ed device 
implements features and benefits that cost-effectively match the needs for POC diagnostics applications. 
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